reference/14213700

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14213700

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	609
issn	1573-0646 0167-6997
issueIdentifier	3
pageRange	599-609
publicationName	Investigational New Drugs
startingPage	599
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dcf08bb9aadf1b4c7a66eb5980c92123 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4720625d96d1f48a0a9d227facc5d786
bibliographicCitation	Li Y, Wang K, Song N, Hou K, Che X, Zhou Y, Liu Y, Zhang J. Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma. Invest New Drugs. 2020 Jun;38(3):599–609. doi: 10.1007/s10637-019-00802-7. PMID: 31177400.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cdaf52a3e80406af451b4758cba2d23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cf39747312c7cdd1f46666a888b41da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4646498f757290d67df69d3d2e2589f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2452a31c35096afff24f59820b5757d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59e0c848dad78ca4f212f854b462de45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0711-2764 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c075bb6fb5b7104f034b47a836062430 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3f14ddf1879edf17837f092eb575eb2
date	2019-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10637-019-00802-7 https://pubmed.ncbi.nlm.nih.gov/31177400
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372 https://portal.issn.org/resource/ISSN/1573-0646 https://portal.issn.org/resource/ISSN/0167-6997
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0228330 http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0328256 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0026587 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M0278625
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25134326 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3914350519c55196e39db45b5e4f14b5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57390074 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49806720 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57379345 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10079 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16038120

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3480 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4869 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID238

Total number of triples: 54.